Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Health Lab
Comprehensive Sequencing Program Shows Promise of Precision Medicine for Advanced Cancer
See the research method and results of a study involving DNA and RNA sequencing of solid tumors and how these findings may inform precision cancer treatment.
Health Lab
How Family and Friends Influence Breast Cancer Treatment Decisions
Read the results of a study investigating the role of family and friends in breast cancer treatment decisions and find out how physicians can use this information to guide conversations with patients.
Health Lab
Precision Medicine: the Promise vs. the Reality
Learn how the use of precision medicine and genetic sequencing are gaining traction within the research community and ongoing clinical trails.
Health Lab
Annual ASCO Meeting Suggests an Optimistic Future for Cancer Care
Michigan Medicine oncologists highlight some of the top findings that came from the field’s largest professional meeting.
Health Lab
Genetic Sequencing Can Influence Treatment for Advanced Cancer
As more biomarker-based studies open, such testing will increase opportunities to match patients with clinical trials.
Health Lab
Complications from Thyroid Cancer Surgery More Common Than Believed, Study Finds
A large, population-based study identifies three groups most at risk of postoperative complications.
Health Lab
How Technology Is Making Prostate Cancer Biopsies More Precise
Learn more about how Michigan Medicine specialists are combining new techniques to improve prostate cancer diagnosis.
Health Lab
A Team Approach and Clinical Trials Push Rectal Cancer Care Forward
High-quality imaging, surgical expertise and ongoing research will help specialists treat the complexities of rectal cancer while preserving patients’ quality of life.
Health Lab
Finding a Way to Hit an ‘Undruggable’ Prostate Cancer Target
A novel strategy to target a genetic anomaly that occurs in half of all prostate cancers may provide a path for developing new therapies against it.
Health Lab
Study Finds Not All Women Get Appropriate Care for Cervical Cancer
Learn more about the findings from a study analyzing records from 16,195 patients treated between 2004 and 2012 for locally advanced cervical cancer.
Health Lab
Looking Beyond Cancer Cells to Understand What Makes Breast Cancer Spread
Get the latest information on how DDR2 contributes to the spread of breast cancer from researchers University of Michigan Comprehensive Cancer Center.
Medicine at Michigan
Cancer Center Leadership
Eric Fearon becomes center’s new director
Health Lab
The Best Treatment for Laryngeal Cancer? This Approach Helps Decide
Laryngeal cancer treatments include chemoradiation & surgery. U-M oncology team offers an approach for deciding between chemotherapy & radiation and surgery.
Health Lab
Half of Breast Cancer Patients Experience Severe Side Effects
93 percent of early stage breast cancer patients experience cancer treatment side effects. See the survey results & common breast cancer treatment side effects.
Health Lab
Study Challenges Potential Pancreatic Cancer Target
Study shows inhibiting the PDX1 protein stops pancreatic cancer growth, but makes the cancer more aggressive. Learn more about this pancreatic cancer treatment.
